747110
Last Update Posted: 2012-06-26
Recruiting has ended
All Genders accepted | 18 Years-75 Years |
343 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
The purpose of this study is to prove the therapeutic equivalence and safety of once-daily 9 mg budesonide versus 3 g mesalazine in a 8-week treatment in patients with active ulcerative colitis.
Eligibility
Relevant conditions:
Colitis, Ulcerative
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov